Skip to main content
Equibles

FIRST TRUST ADVISORS LP

Position in TGTX — Tg Therapeutics, Inc.

CIK 1125816 Wheaton, IL
Back to TGTX Full portfolio

Position in TGTX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$9,155,970
+$7,496,731 QoQ
Shares Held
166,654
+233.7% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#74
of 426 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FIRST TRUST ADVISORS LP holds $2,844,450,753 across 98 Biotechnology names. TGTX ranks #45 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 547,132 $341,158,687
2 INCY
Incyte Corp
 1,587,996 $180,015,226
3 CORT
Corcept Therapeutics Inc
 1,829,545 $159,078,937
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,179 $143,643,884
5 EXEL
Exelixis, Inc.
 2,543,353 $138,383,836
6 ALNY
Alnylam Pharmaceuticals, Inc.
 421,534 $126,894,380
7 KRYS
Krystal Biotech, Inc.
 324,900 $120,755,583
8 AXSM
Axsome Therapeutics, Inc.
 482,061 $117,994,070

All Filings in TGTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,155,970 166,654
2026-03-31 $1,659,239 49,947
2025-12-31 $2,637,946 88,492
2025-09-30 $5,191,270 143,703
2025-06-30 $7,103,742 197,381
2025-03-31 $8,784,688 222,792
2024-12-31 $8,292,429 275,496
2024-09-30 $663,129 28,351
2024-06-30 $2,789,970 156,828
2024-03-31 $2,563,828 168,562
2023-12-31 $658,724 38,567
2023-09-30 $1,185,280 141,780
2023-06-30 $3,943,300 158,748
2021-09-30 $722,841 21,720
2021-06-30 $1,711,569 44,124
2021-03-31 $3,845,396 79,780
2020-12-31 $3,843,965 73,894
2020-09-30 $2,185,489 81,670
2020-06-30 $2,107,930 108,210